<p>Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

Published:2019-02 Issue: Volume:Volume 11 Page:1289-1297
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Redig Josefine^ORCID,Dalén Johan,Harmenberg Ulrika,Lindskog Magnus,Ljungberg Börje,Lundstam Sven,Sandin Rickard,Wahlgren Thomas^ORCID,Åkerborg Örjan,Jakobsson Maria

Publisher

Informa UK Limited

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scoping review of economic analyses of rare kidney diseases;Kidney International Reports;2024-09

2. Consensus Statements on Precision Oncology in the China Greater Bay Area;JCO Precision Oncology;2023-06

3. Socio‐economic burden of disease: Survivorship costs for renal cell carcinoma;European Journal of Cancer Care;2022-03-15

4. Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis;Frontiers in Pharmacology;2021-10-19

5. Changes in therapy and survival of metastatic renal cell carcinoma in Estonia;BMC Cancer;2020-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP